Mode
Text Size
Log in / Sign up

3D CT and angiography show variable accuracy for PDA stent sizing depending on ductal tortuosity

3D CT and angiography show variable accuracy for PDA stent sizing depending on ductal tortuosity
Photo by Nathan Rimoux / Unsplash
Key Takeaway
Consider ductal tortuosity when selecting imaging modality for PDA stent sizing.

This cohort study evaluated 21 consecutive PDA stenting cases at Sheba Medical Center from January 2021 to October 2023. The population had a median age of 14 days and mean weight of 3.6 kg. The study compared pre-procedural three-dimensional computed tomography-derived measurements with traditional angiographic assessments for accuracy in PDA stent sizing.

For the primary outcome of accuracy for stent sizing, overall correlation with stent length was r = 0.692 for 3D CT and r = 0.811 for angiography. When stratified by ductal tortuosity, angiography demonstrated favorable accuracy in straight ducts (Group 1, n=6) with bias of 1.33 mm and concordance correlation coefficient of 0.807. In moderate tortuosity (Group 2, n=3), angiography showed greater underestimation (bias: -5.67 mm) and lower concordance (CCC: 0.168) compared to 3D CT (bias: -2.33 mm; CCC: 0.526). In severe tortuosity (Group 3, n=12), 3D CT overestimated length (bias: +3.1 mm) while angiography underestimated (bias: -2.88 mm), with angiography showing higher consistency (CCC: 0.704 vs 0.559).

Safety and tolerability data were not reported. The study was limited by its small sample size, single-center design, and lack of reported safety outcomes. The authors recommend a complexity-stratified imaging approach to optimize stent selection, but these findings require validation in larger, prospective studies before clinical implementation.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedMar 2026
View Original Abstract ↓
BackgroundPatent Ductus Arteriosus (PDA) stenting has become an established albeit complex intervention in ductal dependent congenital heart disease. Accurate pre-procedural planning is essential for successful stent placement, yet the optimal measurement methodology remains debated. This study compared the accuracy and clinical utility of routine pre-procedural three-dimensional (3D) computed tomography-derived measurements with traditional angiographic assessments for PDA stent sizing.MethodsWe analyzed 21 consecutive PDA stenting cases from Sheba Medical Center (01/2021–10/2023) with a median age of 14 days (IQR: 8–19) and mean weight of 3.6 ± 2.2 kg. Patients were stratified by anatomical complexity: Group 1 (0 turns, n = 6), Group 2 (1 turn, n = 3), and Group 3 (≥2 turns, n = 12). PDA length measurements from CTA-derived 3D reconstruction and 2D angiography were compared against the actual stent length used. Statistical analysis included Pearson correlation, Bland–Altman agreement, and concordance correlation coefficients (CCC).ResultsIn the overall cohort, both 3D (r = 0.692) and angiographic (r = 0.811) measurements correlated with stent length. Performance varied significantly by anatomical complexity. In Group 1 (straight), angiography demonstrated favorable accuracy with lower bias (−0.28 mm vs. 1.33 mm) and higher concordance (CCC: 0.807 vs. 0.681). In Group 2 (moderate tortuosity), angiographic performance showed greater underestimation and lower concordance (Bias −5.67 mm; CCC: 0.168), while 3D remained reliable (Bias −2.33 mm; CCC: 0.526). In Group 3 (severe tortuosity), 3D overestimated length (+3.1 mm) while angiography underestimated it (−2.88 mm), though angiographic consistency was higher (CCC: 0.704 vs. 0.559).ConclusionPre-procedural 3D measurements provide consistent reliability across varying degrees of anatomical complexity, offering an advantage in cases with moderate tortuosity where angiography may be vulnerable to foreshortening. Angiography remains highly accurate for straightforward anatomy. A complexity-stratified imaging approach is recommended to optimize stent selection.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.